Indication | Context | ||
---|---|---|---|
Clinical | Cost constraint | Cost and blood supply constraint | |
Erythropoietin alone, n = 192 | |||
Mean score* | 5.7 | 4.7 | 5.6 |
Variation from the clinical scenario† | NA | −1.0 (p < 0.0001) | −0.1 (p = 0.04) |
Erythropoietin and PAD, n = 72 | |||
Mean score* | 7.3 | 6.1 | 7.0 |
Variation from the clinical scenario† | NA | −1.2 (p < 0.0001) | −0.3 (p < 0.0001) |